NewDays Raises $16M for AI Dementia Care
NewDays expanded its seed round to $16M and brought its AI-driven dementia care platform to Nevada.
Dementia care is one of the clearest places where technology has to support people, not replace them.
What happened
NewDays expanded its seed round to $16M and launched its AI-driven dementia care platform in Nevada. The company combines virtual dementia care, specialist support and AI-guided exercises for people with early dementia and mild cognitive impairment.
Its model is focused on supporting patients and families between traditional clinical visits, where much of the day-to-day care burden usually sits.
Why it matters
Dementia care is capacity-constrained and emotionally difficult. Specialist access is limited, caregivers carry heavy responsibility and patients often need ongoing support that health systems struggle to provide consistently.
NewDays is a useful AI-healthtech signal because it applies AI to care delivery and therapy support, not just documentation or billing automation.
The bigger picture
Digital health is becoming more credible when it focuses on specific care pathways. Dementia, neurorehabilitation, oncology and chronic care all require ongoing engagement, monitoring and support. AI can help scale parts of that model, but the companies that succeed will need strong clinical oversight and careful trust-building with patients and caregivers.